Explores the mental, physical, cellular and biochemical aspects of environmental illnesses such as obesity, diabetes, chronic fatigue syndrome, PTSD, fibromyalgia, chemical sensitivities, neurological disorders and numerous others. We advocate for better access to medical care, healthier lifestyles, resource conservation and the use of assistance animals for the disabled to promote a better quality of life.
Friday, January 29, 2010
Inhibition of liver fibrosis by solubilized coenzyme Q10: Role of Nrf2 activation in inhibiting transforming growth factor-beta1 expression.
CiteULike: Inhibition of liver fibrosis by solubilized coenzyme Q10: Role of Nrf2 activation in inhibiting transforming growth factor-beta1 expression.: "Choi, H.-K. K., Pokharel, Y. R. R., Lim, S. C. C., Han, H.-K. K., Ryu, C. S. S., Kim, S. K. K., Kwak, M. K. K., and Kang, K. W. W. (2009). Inhibition of liver fibrosis by solubilized coenzyme q10: Role of nrf2 activation in inhibiting transforming growth factor-beta1 expression. Toxicology and applied pharmacology, 240(3):377-384."
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment